Oseltamivir is a potent antiviral agent belonging to the neuraminidase inhibitor class, widely prescribed for the treatment and prevention of influenza A and B virus infections. By competitively inhibiting… Read more


















































Oseltamivir is a potent antiviral agent belonging to the neuraminidase inhibitor class, widely prescribed for the treatment and prevention of influenza A and B virus infections. By competitively inhibiting the viral neuraminidase enzyme, it prevents the release of new viral particles from infected cells. For pharmaceutical laboratories, accurate analysis of this drug is critical, requiring a comprehensive set of reference standards. The available collection includes essential materials for impurity profiling, such as process-related degradants and pharmacopeial impurities, which are necessary for method validation and regulatory compliance. Additionally, stable isotope labelled compounds are used as internal standards in advanced mass spectrometry-based analytical methods to ensure precision in quantification. Together, these reference materials support rigorous quality control processes throughout the lifecycle of the active pharmaceutical ingredient, helping to maintain high standards of safety and efficacy in antiviral medication development and testing.